Literature DB >> 18676688

Fasudil inhibits the myogenic response in the fetal pulmonary circulation.

Pierre Tourneux1, Marc Chester, Theresa Grover, Steven H Abman.   

Abstract

In addition to high pulmonary vascular resistance (PVR) and low pulmonary blood flow, the fetal pulmonary circulation is characterized by mechanisms that oppose vasodilation. Past work suggests that high myogenic tone contributes to high PVR and may contribute to autoregulation of blood flow in the fetal lung. Rho-kinase (ROCK) can mediate the myogenic response in the adult systemic circulation, but whether high ROCK activity contributes to the myogenic response and modulates time-dependent vasodilation in the developing lung circulation are unknown. We studied the effects of fasudil, a ROCK inhibitor, on the hemodynamic response during acute compression of the ductus arteriosus (DA) in chronically prepared, late-gestation fetal sheep. Acute DA compression simultaneously induces two opposing responses: 1) blood flow-induced vasodilation through increased shear stress that is mediated by NO release and 2) stretch-induced vasoconstriction (i.e., the myogenic response). The myogenic response was assessed during acute DA compression after treatment with N(omega)-nitro-L-arginine, an inhibitor of nitric oxide synthase, to block flow-induced vasodilation and unmask the myogenic response. Intrapulmonary fasudil infusion (100 microg over 10 min) did not enhance flow-induced vasodilation during brief DA compression but reduced the myogenic response by 90% (P<0.05). During prolonged DA compression, fasudil prevented the time-dependent decline in left pulmonary artery blood flow at 2 h (183+/-29 vs. 110+/-11 ml/min with and without fasudil, respectively; P<0.001). We conclude that high ROCK activity opposes pulmonary vasodilation in utero and that the myogenic response maintains high PVR in the normal fetal lung through ROCK activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676688      PMCID: PMC2593508          DOI: 10.1152/ajpheart.00490.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  48 in total

1.  In vivo evidence for a myogenic response in the fetal pulmonary circulation.

Authors:  L Storme; R L Rairigh; T A Parker; J P Kinsella; S H Abman
Journal:  Pediatr Res       Date:  1999-03       Impact factor: 3.756

2.  THE VASCULAR RESISTANCE OF THE FOETAL AND NEWLY VENTILATED LUNG OF THE LAMB.

Authors:  S CASSIN; G S DAWES; J C MOTT; B B ROSS; L B STRANG
Journal:  J Physiol       Date:  1964-05       Impact factor: 5.182

3.  The vascular tone of the foetal lung.

Authors:  G S DAWES; J C MOTT
Journal:  J Physiol       Date:  1962-12       Impact factor: 5.182

4.  Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.

Authors:  Y Fukumoto; T Matoba; A Ito; H Tanaka; T Kishi; S Hayashidani; K Abe; A Takeshita; H Shimokawa
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

5.  Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure.

Authors:  H J Knot; M T Nelson
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

6.  Endothelin blockade augments pulmonary vasodilation in the ovine fetus.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Appl Physiol (1985)       Date:  1996-12

Review 7.  The lungs at birth.

Authors:  L B Strang
Journal:  Arch Dis Child       Date:  1965-12       Impact factor: 3.791

8.  Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes.

Authors:  A M Rudolph; S Yuan
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

9.  Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

Authors:  Karen A Fagan; Masahiko Oka; Natalie R Bauer; Sarah A Gebb; D Dunbar Ivy; Kenneth G Morris; Ivan F McMurtry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

10.  Persistent pulmonary hypertension of the newborn infant.

Authors:  D L Levin; M A Heymann; J A Kitterman; G A Gregory; R H Phibbs; A M Rudolph
Journal:  J Pediatr       Date:  1976-10       Impact factor: 4.406

View more
  15 in total

Review 1.  Bringing down the ROS: a new therapeutic approach for PPHN.

Authors:  Amy L Firth; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-17       Impact factor: 5.464

2.  Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia.

Authors:  Joshua R Sheak; Laura Weise-Cross; Ray J deKay; Benjimen R Walker; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

Review 3.  Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Authors:  Demosthenes G Papamatheakis; Madalitso Chundu; Arlin B Blood; Sean M Wilson
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 4.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

5.  Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Katherine Kuhn; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-19       Impact factor: 5.464

6.  Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep.

Authors:  Jason Gien; Nancy Tseng; Gregory Seedorf; Gates Roe; Steven H Abman
Journal:  Pediatr Res       Date:  2012-11-30       Impact factor: 3.756

7.  Effects of pathological flow on pulmonary artery endothelial production of vasoactive mediators and growth factors.

Authors:  Min Li; Kurt R Stenmark; Robin Shandas; Wei Tan
Journal:  J Vasc Res       Date:  2009-06-30       Impact factor: 1.934

Review 8.  Antenatal hypoxia and pulmonary vascular function and remodeling.

Authors:  Demosthenes G Papamatheakis; Arlin B Blood; Joon H Kim; Sean M Wilson
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

9.  Role of dual-specificity protein phosphatase-5 in modulating the myogenic response in rat cerebral arteries.

Authors:  Nadi T Wickramasekera; Debebe Gebremedhin; Koryn A Carver; Padmanabhan Vakeel; Ramani Ramchandran; Aaron Schuett; David R Harder
Journal:  J Appl Physiol (1985)       Date:  2012-11-21

Review 10.  Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Authors:  Christopher D Baker; Steven H Abman; Peter M Mourani
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.